CADTH | Homepage

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

National Capital Region's Top Employers 2024 logo

A National Capital Region’s top employer

National Capital Region's Top Employers 2024 logo

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Latest News

A Statement From Suzanne McGurn, President and CEO, CADTH On behalf of the organization and our Board of Directors, I’m pleased to share the Annual ...
Target Zero is a new initiative that aims to improve the time to access for patients in Canada for new drugs that are proven to be effective. The ...
CADTH has developed a comprehensive and accessible tool to support the validation of economic models used in health technology assessments (HTAs). Econ ...
We are testing a new approach that brings the societal perspective to our economic evaluations of certain new drugs. When a drug sponsor submits a drug ...
Current Consultation Status: Open Consultation Period Extended: March 28 to May 3, 2024 CADTH is updating the procedures for provisional funding ...
Qualified rare disease registry owners can submit funding proposals to enhance the infrastructure, data quality, and utility of rare disease ...

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

Payer Summit ISPOR 2024

12:00pm

The Inside Affair

8:00 am

HTAi 2024 Annual Meeting

-
8:00 am
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.